These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 32517089)

  • 1. Long Non-Coding RNA HAND2-AS1 Acts as a Tumor Suppressor in High-Grade Serous Ovarian Carcinoma.
    Gokulnath P; de Cristofaro T; Manipur I; Di Palma T; Soriano AA; Guarracino MR; Zannini M
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA HAND2-AS1 inhibits invasion and metastasis in endometrioid endometrial carcinoma through inactivating neuromedin U.
    Yang X; Wang CC; Lee WYW; Trovik J; Chung TKH; Kwong J
    Cancer Lett; 2018 Jan; 413():23-34. PubMed ID: 29107108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA HAND2-AS1 exerts anti-oncogenic effects on ovarian cancer via restoration of BCL2L11 as a sponge of microRNA-340-5p.
    Chen J; Lin Y; Jia Y; Xu T; Wu F; Jin Y
    J Cell Physiol; 2019 Dec; 234(12):23421-23436. PubMed ID: 31222748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA HAND2-AS1 inhibits cancer cell proliferation, migration, and invasion in esophagus squamous cell carcinoma by regulating microRNA-21.
    Yan Y; Li S; Wang S; Rubegni P; Tognetti L; Zhang J; Yan L
    J Cell Biochem; 2019 Jun; 120(6):9564-9571. PubMed ID: 30520131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma.
    Norris EJ; Zhang Q; Jones WD; DeStephanis D; Sutker AP; Livasy CA; Ganapathi RN; Tait DL; Ganapathi MK
    J Pathol; 2019 Jul; 248(3):352-362. PubMed ID: 30883751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation of Genes in New Long Noncoding RNA in Ovarian Tumors and Metastases: A Dual Effect.
    Burdennyy AM; Filippova EA; Ivanova NA; Lukina SS; Pronina IV; Loginov VI; Fridman MV; Kazubskaya TP; Utkin DO; Braga EA; Kushlinskii NE
    Bull Exp Biol Med; 2021 Jul; 171(3):370-374. PubMed ID: 34292442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells.
    Li H; Zhou Y; Cheng H; Tian J; Yang S
    Exp Mol Pathol; 2020 Aug; 115():104481. PubMed ID: 32497621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of long noncoding RNAs downregulated specifically in ovarian high-grade serous carcinoma.
    Hayashi-Okada M; Sato S; Nakashima K; Sakai T; Tamehisa T; Kajimura T; Tamura I; Sueoka K; Sugino N
    Reprod Med Biol; 2024; 23(1):e12572. PubMed ID: 38571514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene microarray analysis of lncRNA and mRNA expression profiles in patients with high‑grade ovarian serous cancer.
    Lou Y; Jiang H; Cui Z; Wang X; Wang L; Han Y
    Int J Mol Med; 2018 Jul; 42(1):91-104. PubMed ID: 29577163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA HAND2-AS1 inhibits proliferation and promotes apoptosis of chronic myeloid leukemia cells by sponging with micRNA-1275.
    Yang JR; Shi MX; Zeng Y
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2103-2111. PubMed ID: 30915755
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Saini U; Suarez AA; Naidu S; Wallbillich JJ; Bixel K; Wanner RA; Bice J; Kladney RD; Lester J; Karlan BY; Goodfellow PJ; Cohn DE; Selvendiran K
    Cancer Res; 2018 Apr; 78(7):1739-1750. PubMed ID: 29339537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA HAND2-AS1 represses cervical cancer progression by interaction with transcription factor E2F4 at the promoter of C16orf74.
    Gong J; Fan H; Deng J; Zhang Q
    J Cell Mol Med; 2020 Jun; 24(11):6015-6027. PubMed ID: 32314545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA HAND2-AS1 restrains proliferation and metastasis of breast cancer cells through sponging miR-1275 and promoting SOX7.
    Wang Y; Cai X
    Cancer Biomark; 2020; 27(1):85-94. PubMed ID: 31683462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding RNA MAGI2-AS3 is a New Player with a Tumor Suppressive Role in High Grade Serous Ovarian Carcinoma.
    Gokulnath P; de Cristofaro T; Manipur I; Di Palma T; Soriano AA; Guarracino MR; Zannini M
    Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31842477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma.
    Ghannam-Shahbari D; Jacob E; Kakun RR; Wasserman T; Korsensky L; Sternfeld O; Kagan J; Bublik DR; Aviel-Ronen S; Levanon K; Sabo E; Larisch S; Oren M; Hershkovitz D; Perets R
    Oncogene; 2018 Apr; 37(17):2213-2224. PubMed ID: 29379162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Genomic Sequencing Reveals Novel
    Jung YY; Woo HY; Kim HS
    Anticancer Res; 2019 Jun; 39(6):2883-2889. PubMed ID: 31177126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA FAM83H-AS1 contributes to the radioresistance, proliferation, and metastasis in ovarian cancer through stabilizing HuR protein.
    Dou Q; Xu Y; Zhu Y; Hu Y; Yan Y; Yan H
    Eur J Pharmacol; 2019 Jun; 852():134-141. PubMed ID: 30831080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Non-coding RNA
    Yim GW; Kim HJ; Kim LK; Kim SW; Kim S; Nam EJ; Kim YT
    Cancer Res Treat; 2017 Jul; 49(3):656-668. PubMed ID: 27737536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer.
    Fang L; Wang H; Li P
    Invest New Drugs; 2018 Apr; 36(2):187-194. PubMed ID: 29082457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.